Medicine and Dentistry
Sickle-Cell Disease
100%
Patient with Sickle Cell Disease
24%
Intensive Care
18%
Blood Transfusion Reaction
18%
Disease Severity
17%
Exchange Blood Transfusion
9%
Diseases
9%
Prognostic Factor
9%
Body Mass Index
9%
Non Invasive Procedure
9%
Liver Disease
9%
Intensive Care Unit
9%
Health System
9%
Cohort Analysis
9%
Liver Injury
9%
Liver Transplantation
9%
Epidural Hematoma
9%
Moyamoya Disease
9%
Transient Elastography
9%
Embryonic Hemoglobin
9%
Neurological Complication
9%
Apoplexy
9%
Intracranial Aneurysm
9%
Oxidative Stress
9%
Erythrocyte Transfusion
7%
Reticulocyte
7%
Thalassemia
6%
Liver Fibrosis
6%
Prevalence
5%
Hydroxyurea
5%
Leukocyte
5%
Bilirubin
5%
Blood Transfusion
5%
Biochemistry, Genetics and Molecular Biology
Embryonic Hemoglobin
33%
Genetics
20%
Genetic Divergence
13%
Fetal Hemoglobin
13%
Allele
11%
Genetic Determinism
10%
BCL11A
10%
Genetic Model
9%
Haplotype
9%
Cohort Study
9%
Intron
9%
Body Mass
9%
Single Nucleotide Polymorphism
5%
Nursing and Health Professions
Sickle Cell Anemia
37%
Intensive Care
18%
Clinical Audit
9%
Advisory Committee
9%
Body Mass
9%
Intensive Care Unit
9%
Disease Severity
7%
